# US 10,369,179 B2 · Composition of Mangifera indica

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 10,369,179 B2
- Document ID: US10369179B2
- Status: Granted
- Kind: B2
- Application number: 14/852,604
- Filed: 2015-09-13
- Published: 2017-03-16
- Granted: 2019-08-06
- Earliest claimed: 2015-09-13
- Assignees: Vidya Herbs, Inc.
- Applicants: Kodimule Shyam Prasad
- Inventors: Kodimule Shyam Prasad
- Web page: https://patentgrep.com/patent/US10369179B2

## CPC

- A61K 36/22: Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
- A61K 9/0053: {Mouth and digestive tract, i.e. intraoral and peroral administration}
- A61K 31/353: 3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K 31/7048: having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin {, digitoxin or digoxin}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The invention relates to a herbal composition derived from Mangifera indica. Methods of making and using the composition for the management of obesity are also contemplated.

## Claims

### Claim 1

A composition comprising:
about 22% mangiferin,
about 4% catechin,
about 3% epicatechin
about 0.4% quercetin dihydrate,
4.5+/−0.42% gallic acid;
0.93+/−0.23% 3,4 dihydroxy benzoic acid;
1.2+/−0.34% methyl gallate;
2.31+/−0.73% propyl gallate;
0.48+/−0.08% pyrogallol;
1.43+/−0.07% parahydroxy benzoic acid;
0.33+/−0.06% vanillic acid;
0.82+/−0.13% syringic acid;
0.12+/−0.02% ferulic acid;
0.76+/−0.14% ethyl gallate; and
0.16+/−0.05% ellagic acid;
wherein said composition has a total flavonoid content of about 29% and a total polyphenol content of about 19%, and
wherein said composition is in an administration form selected from the group consisting of: a pill, tablet, capsule, lozenge, chewing gum, emulsion, topical patch, buccal patch, and gummy.

### Claim 2 (depends on 1)

The composition of claim 1, wherein said composition further comprises an excipient.

### Claim 3 (depends on 1)

The composition of claim 1, wherein said composition further comprises a sweetener, aromatic, flavoring, or combinations thereof.

### Claim 4 (depends on 1)

The composition of claim 1, wherein said composition further comprises a mineral, protein, amino acid, carbohydrate, or combinations thereof.

### Claim 5 (depends on 1)

The composition of claim 1, wherein said composition inhibits lipase activity by about 52% at a concentration of about 100 μg/ml in vitro.